Clinical trials
Withdrawn Phase 2 Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
59 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2006 | 3 |
| 2007 | 1 |
| 2008 | 4 |
| 2010 | 5 |
| 2011 | 2 |
| 2012 | 3 |
| 2013 | 3 |
| 2014 | 5 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 5 |
| 2018 | 3 |
| 2019 | 6 |
| 2020 | 2 |
| 2021 | 4 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 59 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| GlaxoSmithKline | 4 |
| Astellas Pharma Global Development, Inc. | 2 |
| Teresa Helsten, MD | 2 |
| AbbVie | 1 |
| Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 1 |
| Asan Medical Center | 1 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Barretos Cancer Hospital | 1 |
| Berufsverband Niedergelassener Gynäkologischer Onkologen in Deutschland e.V. | 1 |
| Canadian Myeloma Research Group | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neoplasms | 59 |
| Neoplasm Metastasis | 8 |
| Pancreatic Neoplasms | 5 |
| Multiple Myeloma | 4 |
| Brain Neoplasms | 3 |
| Carcinoma, Non-Small-Cell Lung | 3 |
| Recurrence | 3 |
| Acrocephalosyndactylia | 2 |
| Carcinoma | 2 |
| Cholangiocarcinoma | 2 |
Trials
Showing 1 to 25 of 59. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.